Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 1471
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49199
That's why we have the tag team last night and
(4)
Drano
09/24/2018 9:36:48 AM
49198
Funny this fluff business. I have not been able
(1)
RusticBum
09/24/2018 9:35:48 AM
49197
Well they do, BP needs to make sure that their
(3)
zdubble17
09/24/2018 9:35:44 AM
49196
Over the last 5 years my two largest holdings:
(1)
NickAidenNY
09/24/2018 9:27:04 AM
49195
That PR tells me that Leo is extremely confident
(2)
smokenhot
09/24/2018 9:23:56 AM
49194
Love the management comments and sure sounds like
(2)
AlanC
09/24/2018 9:22:45 AM
49193
Funny that the multi ID's talk about trial
(3)
Kelt
09/24/2018 9:14:20 AM
49192
Thanks. My youth came flashing back; the times
(1)
RusticBum
09/24/2018 8:54:31 AM
49191
Looking forward to see what October
bejamin
09/24/2018 8:48:14 AM
49190
Where did I say that IV drug works better? As
(1)
RusticBum
09/24/2018 8:47:52 AM
49189
Not a real big fan of this PR. If there is a
(2)
bejamin
09/24/2018 8:47:24 AM
49188
Excellent article showing why B-OM the leader of
(2)
petemantx
09/24/2018 8:37:30 AM
49187
What concern would a BP have with what IPIX is
(1)
petemantx
09/24/2018 8:29:11 AM
49186
Alan saw your post after I posted. Nice to see!
4kids
09/24/2018 8:11:45 AM
49185
News alert per Fidelity. Traveling so maybe
4kids
09/24/2018 8:04:19 AM
49184
Innovation Pharmaceuticals Provides a Comparative
(1)
AlanC
09/24/2018 7:43:26 AM
49183
If Leo doesn't have a deal done in October and
bejamin
09/24/2018 7:37:11 AM
49182
To finish, I think were buying time till 1st
(3)
Trading Pro Broker
09/24/2018 7:36:05 AM
49181
Good reminder to folks on the value of B-OM. A
Trading Pro Broker
09/24/2018 7:33:06 AM
49180
Very good discussion you started, like to see
bejamin
09/24/2018 7:31:39 AM
49179
https://mailchi.mp/ipharminc/innovation-pharmaceu
(1)
Commando911
09/24/2018 7:23:44 AM
49178
I know I'm not a fan of those who attempt to
(1)
BooDog
09/24/2018 7:23:39 AM
49177
and a PR on OM
smokenhot
09/24/2018 7:16:38 AM
49176
New B-OM comparison Blog
(2)
smokenhot
09/24/2018 7:02:28 AM
49175
IMO A big Pharma is doing due diligence and found
zdubble17
09/23/2018 11:08:54 PM
49174
I agree...but Im not concerned. If money were
Commando911
09/23/2018 10:25:10 PM
49173
No, it's not medical semantics. You're making a
(5)
Drano
09/23/2018 8:35:45 PM
49172
I think I love you!!! Kelt
Kelt
09/23/2018 8:33:16 PM
49171
Seemingly contrary. Over differences are over
(1)
RusticBum
09/23/2018 8:19:10 PM
49170
Nothing strange at all about not paying someone
(2)
Drano
09/23/2018 7:52:35 PM
49169
No, the board is not "alarmingly paranoid."
(5)
Drano
09/23/2018 7:50:29 PM
49168
The timing just seems weird to me. IPIX is close
smokenhot
09/23/2018 7:37:17 PM
49167
What makes you think that lesions show up fully
(2)
RusticBum
09/23/2018 5:27:56 PM
49166
My bet is you get to stock the Scotch, maybe
incubus
09/23/2018 5:14:05 PM
49165
Please don't let facts get in the way of your
(4)
Drano
09/23/2018 4:37:48 PM
49164
As you said Brilacidin does not have systemic
(2)
RusticBum
09/23/2018 4:17:29 PM
49163
Well here we are folks at the last trading week
(12)
Kelt
09/23/2018 1:42:25 PM
49162
Ahhh Yes. A little word twisting here,a little
(2)
Kelt
09/23/2018 1:40:12 PM
49161
Menon is in his mid-70's and was already on half
Drano
09/23/2018 1:36:55 PM
49160
Is it possible that Menon's termination has
smokenhot
09/23/2018 1:18:21 PM
49159
We have only people's word for it that they are
(2)
Drano
09/23/2018 12:58:15 PM
49158
That is incorrect. Bril-OM PREVENTS lesions from
(6)
Drano
09/23/2018 12:40:39 PM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
49153
NO way will an insurance company pay for that
(2)
smokenhot
09/22/2018 3:24:06 PM
49152
He's accusing long-time posters of being
(5)
Drano
09/22/2018 2:27:16 PM
49150
Take a look at Galas OM drug. Its
(1)
Trading Pro Broker
09/22/2018 1:38:41 PM
49149
Id like to see Leo take half his compensation
(2)
Commando911
09/22/2018 1:19:15 PM
Newer
Older
Recent Articles
Haier LED TVs Achieve Milestone with EU Accessibility Certification
Vehere Enhances Cyber Defense with Version 1.8.1 Update
KUN Advances Global Payments with $50M Series A Funding Success
Comprehensive Transmission Services Now Available at Flagship Mazda
Exploring the Rapid Growth of Drone Companies in 2024
Nykredit Invest Balance Updates on Suspension Lifting News
SparDanmark Invest Resumes Trading Across Multiple Funds
Resumption of Trading for Multi Manager Invest Fund Units
Innovative Megawatt Charging Systems Set to Transform EV Market
Market Movements: Gold and Currencies Respond to Economic Data
21Shares Mid-Year Crypto Review 2025: Key Insights and Trends
Navigating Principal Trading with Dowlais Group plc Explained
Study Confirms Safety of Combined Eye Drops for Surgery Use
Skyrocketing Demand for Data Center Switch Networks Amid AI Growth
Groundbreaking Chiropractic Program Launches in Phoenix Region
Disneyland Resort Sets the Stage for 70th Anniversary Celebration
Investment in Advanced Quantum Computing for the Nordics
NTC's Five-Year Study Validates Safety of Eye Drop Treatment
Challenges Facing ECB Amid Tariff Threats and Euro Strength
ProVen VCT plc Reports Steady Performance and Growth Update
ProVen VCT plc's Strong Performance in Recent Management Update
GAC Partners with Jameel Motors to Expand into Europe and UK
Vinamilk's Revolutionary 6-HMO Formula Shines at Summit
Celebrating Excellence: Joseph Spine Institute's Top Docs of 2025
Goldman Sachs Unveils Significant Dividend Boost Amid Strong Earnings
Suspension of Trading in Selected Departments at Multi Manager Invest
Detailed Disclosure of Interests by Danske Bank on Alpha Group
Man Group PLC Reports Significant Position Disclosures
ProVen Growth and Income VCT's Latest Interim Management Insights
Man Group PLC Positions and Interests Update on Deliveroo
Man Group PLC's Significant Securities Disclosure Explained
Man Group PLC Reveals Key Position Details in Recent Disclosure
Ascentage Pharma Secures Major Funding Through Successful Placement
ProVen Growth and Income VCT plc Shares Show Positive Movement
Insights into Upcoming Earnings Announcements for Companies
Tech Earnings at a Glance: Netflix and TSM on the Radar
Consumer Resilience Fuels Bank of America Amidst Slowing Trends
Key Insights on Alpha Group International's Recent Disclosure
The Cotocon Group Unveils Revolutionary Platform for NYC Owners
Exploring Why Billionaires See Value in High-End Liquor
Understanding Long-Term Yield Movements in Financial Markets
EU Institutions Face Alarming Cybersecurity Performance Gaps
Innovative Dogecoin Protocol Architecture Patent Preparation
Wolters Kluwer's Strategic Share Buyback Program Outcomes
Hepsor AS Announces Significant Capital Increase for Growth
Nykredit Invest Balance Announces Suspension of Selected Departments
SparDanmark Invest Temporarily Suspends Trading of Funds
Wolters Kluwer Shares Repurchase Program Insights
MainStreaming Teams with DAZN to Elevate Viewing Experience
Innovative Provisional Patent Application Enhances Dogecoin Cash